ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Seattle, WA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Seattle, WA, USA:

Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)

SC262-101 is a Phase 1 study to evaluate SC262 safety and tolerability, anti-tumor activity, cellular kinetics, immunogenicity, and exploratory bioma...

Enrolling
Large B-cell Lymphoma
Non Hodgkin's Lymphoma
Drug: SC262

Phase 1

Sana Biotechnology

Seattle, Washington, United States and 2 other locations

This phase II trial studies how well pembrolizumab with rituximab or obinutuzumab work in treating patients with follicular lymphoma or diff...

Active, not recruiting
Recurrent Follicular Lymphoma
Refractory Follicular Lymphoma
Other: Laboratory Biomarker Analysis
Biological: Obinutuzumab

Phase 2

University of Washington
University of Washington

Seattle, Washington, United States

This phase I/II trial studies the safety of acalabrutinib and axicabtagene ciloleucel in treating patients with B-cell lymphoma. Acalabrutin...

Enrolling
Grade 2 Follicular Lymphoma
Grade 1 Follicular Lymphoma
Biological: Axicabtagene Ciloleucel
Drug: Acalabrutinib

Phase 1, Phase 2

University of Washington
University of Washington

Seattle, Washington, United States

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Active, not recruiting
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Tacoma, Washington, United States and 71 other locations

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting
Hodgkin Lymphoma
Drug: vinblastine
Drug: brentuximab vedotin

Phase 3

Takeda
Takeda

Seattle, Washington, United States and 215 other locations

The purpose of this study is to define the recommended Phase 2 Dose, safety, tolerability, immunogenicity, and preliminary efficacy of EO2463 during...

Enrolling
Marginal Zone Lymphoma
Follicular Lymphoma
Biological: rituximab
Biological: EO2463

Phase 1, Phase 2

Enterome

Seattle, Washington, United States and 11 other locations

cell therapy (bridging therapy) in patients with large B-cell lymphomas that have come back after a period of improvement (relapsed) or that...

Begins enrollment this month
Recurrent Grade 3b Follicular Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Procedure: Leukapheresis
Procedure: Positron Emission Tomography

Phase 2

University of Washington
University of Washington

Seattle, Washington, United States

to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...

Enrolling
Lymphoma, Follicular
Drug: Golcadomide
Drug: Doxorubicin

Phase 2

Celgene
Celgene

Seattle, Washington, United States and 67 other locations

of this study is to characterize the safety and efficacy profile of ACP-196 (acalabrutinib) in subjects with relapsed or refractory Mantle Cell Lymphoma...

Active, not recruiting
Mantle Cell Lymphoma (MCL)
Drug: ACP-196 (acalabrutinib)

Phase 2

Acerta Pharma
Acerta Pharma

Seattle, Washington, United States and 57 other locations

patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL) that is newly di...

Enrolling
Refractory Small Lymphocytic Lymphoma
Recurrent Small Lymphocytic Lymphoma
Procedure: Bone Marrow Biopsy
Procedure: Gastrointestinal Endoscopy

Phase 2

Fred Hutchinson Cancer Center (FHCC)
Fred Hutchinson Cancer Center (FHCC)

Seattle, Washington, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems